The aim of this study is to evaluate the efficacy of insulin\like growth factor 1 receptor (IGF\1R) inhibitor Linsitinib, in esophageal squamous cell carcinoma (ESCC), and to characterize special biomarker to display screen Linsitinib\sensitive patients as well as explore the molecular\resistant mechanism to Linsitinib in ESCC. Linsitinib\resistant cells To check if NF\C inhibitor could end… Continue reading The aim of this study is to evaluate the efficacy of